Cannot jinx this thing, should already be over $10 with all that has happened, they just got the bad luck of their company going through its best period during a shitty time in the market.
Buy any hard dips because this one is gonna get moving as it should have a month ago. $$ sorted in non dilutive way for profitable near $100 mil revenue a year acquisition and launch of drug that has no rivals, this is just getting ready to kick, watch.